Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 916 M947 M951 M1.06 B918 M1 B 3.93 B Research & development —————— — Operating income 814 M1.47 B788 M945 M756 M3.48 B 5.97 B Non-Operating Income, Total —————— — Interest expense, net of interest capitalized 207 M197 M186 M167 M154 M157 M 664 M Non-Operating Income, excl. Interest Expenses —————— — Unusual income/expense —————— — Pretax income 687 M1.35 B1.17 B1.29 B1.14 B1.44 B 5.05 B Equity in earnings -13 M4 M6 M-5 M-6 M4 M -1 M Taxes 104 M291 M262 M284 M229 M329 M 1.1 B Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 583 M1.06 B912 M1.01 B915 M1.11 B 3.95 B Discontinued operations —————— — Net income 583 M1.06 B912 M1.01 B915 M1.11 B 3.95 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 583 M1.06 B912 M1.01 B915 M1.11 B 3.95 B Basic earnings per share (Basic EPS) 5.9210.889.4710.589.8112.12 41.98 Diluted earnings per share (Diluted EPS) 5.8310.739.3310.399.6811.98 41.38 Average basic shares outstanding 98.5 M97.4 M96.3 M96.7 M93.3 M91.8 M — Diluted shares outstanding 100 M98.8 M97.8 M98.2 M94.5 M92.9 M — EBITDA 818 M1.47 B1.28 B1.44 B1.22 B1.52 B 5.46 B EBIT 814 M1.47 B1.28 B1.38 B1.22 B1.51 B 5.39 B Cost of revenue 515 M355 M488 M434 M462 M466 M 1.85 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 4 M3 M4 M64 M3 M3 M 74 M